News from

Research

Reset All Filters
1295 Results
A hard reset on electroconvulsive therapy
Medical brain scans on multiple computer screens.

Image: gorodenkoff via Getty Images

A hard reset on electroconvulsive therapy

New research from Penn Medicine finds that ECT sets in motion a brain event that resets its neurons, and has the potential to guide personalized ECT dosing to target specific outcomes in the brain.

From Penn Medicine News

2 min. read

Study finds Scottish Safe Staffing Act implementation facing challenges

Study finds Scottish Safe Staffing Act implementation facing challenges

A new study from Penn’s School of Nursing reveals that the Scotland Act, which aims to ensure safe nurse staffing through guiding principles, duties, and a common staffing method, is not being consistently followed, according to nurses on the frontlines.

From Penn Nursing News

2 min. read

Delivering a one-two punch to superbugs to fight infections
Rakesh Krishnan sits at a computer staring at a 3D rendering of a protein.

Researchers led by César de la Fuente of the Perelman School of Medicine have created new peptides that fight hard-to-treat “superbug” infections by punching holes in bacterial cells and stimulating immune cells to signal for more defenders.

(Image: Courtesy of Jianing Bai) 

Delivering a one-two punch to superbugs to fight infections

Penn researchers create mirror-image molecules that both kill pathogens outright and rally the immune system—an advance aimed at the growing crisis of antimicrobial resistance.

3 min. read

New tools to treat retinal degenerations at advanced stages of disease
Raghavi Sudharsan and William Beltran by a microscope in a lab.

Raghavi Sudharsan and William Beltran of the Division of Experimental Retinal Therapies at Penn’s School of Veterinary Medicine.

nocred

New tools to treat retinal degenerations at advanced stages of disease

A collaborative team of researchers led by vision scientists at the School of Veterinary Medicine have developed novel promoters that drive strong and specific gene expression in rod and cone photoreceptors in mid-to-late stages of disease, potentially offering new and improved options for gene therapy.

3 min. read

Lillian Miller: May grad turned Penn Ph.D.
Lillian Miller and Irina Marinov

Lillian Miller (left) graduated as a chemistry and environmental scieces double major in May. This summer, she returns to begin her graduate training in Irina Marinov’s (right), where researchers use big data and computational techniques to make better climate models.

nocred

Lillian Miller: May grad turned Penn Ph.D.

Lillian Miller, a May graduate from the College, will begin graduate studies in the laboratory of Irina Marinov this summer, where she is leveraging big data to tackle ocean and climate-focused research.

5 min. read

World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration
Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ in the hospital.

Penn Medicine’s Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ post infusion.

(Image: Courtesy of Children’s Hospital of Philadelphia)

World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration

A landmark study from CHOP and Penn Medicine showcases the power of customized gene editing therapy to treat a patient with a rare metabolic disease

Matt Toal

5 min. read